Related Experiment Video
Updated: Mar 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2
Shuo Zhang1,2, Lei Gao1,2, Asmitananda Thakur1,2,3,4
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, People's Republic of China.
Abstract:
MicroRNAs (miRNAs) play a critical role in cancer development and progression. Deregulated expression of miR-204 has been reported in several cancers, but the mechanism through which miR-204 modulates human non-small cell lung cancer (NSCLC) is largely unknown. In this study, we investigate the expression and functional role of miR-204 in human NSCLC tissues and cell lines. RNA isolation, qRT-PCR, MTT, colony formation assay, cell cycle assay, cell apoptosis assay, cell migration assay, and Western blot were performed. Statistical analysis was performed using SPSS 18.0 software and statistical significance was accepted at p value <0.05. miR-204 level was significantly reduced in NSCLC tissues as compared to that of non-neoplastic tissues. Transient over-expression of miR-204 by transfecting with miR-204 mimics suppressed NSCLC cell proliferation, migration, and induced apoptosis and G1 arrest, whereas inhibition of miR-204 showed the converse effects. Additionally, activating transcription factor 2 (ATF2), an important transcription factor, was demonstrated as a potential target gene of miR-204. Subsequent investigations found a negative correlation between miR-204 level and ATF2 expression in NSCLC tissue samples. Moreover, we observed that miR-204 expression inversely affected endogenous ATF2 expression at both mRNA and protein levels in vitro. Taken together, miR-204 may act as a tumor suppressor by directly targeting ATF2 in NSCLC.
Insights
MicroRNA-204 (miR-204) acts as a tumor suppressor in non-small cell lung cancer (NSCLC). Lower miR-204 levels in NSCLC tissues correlate with increased activating transcription factor 2 (ATF2), inhibiting cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators in cancer development.
- The specific role of miR-204 in non-small cell lung cancer (NSCLC) remains largely uncharacterized.
- Dysregulated miR-204 expression is observed in various cancer types.
Purpose of the Study:
- To investigate the expression and functional significance of miR-204 in human NSCLC.
- To identify potential target genes of miR-204 involved in NSCLC pathogenesis.
- To elucidate the mechanism by which miR-204 influences NSCLC progression.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for miRNA expression analysis.
- Cell proliferation (MTT, colony formation), cell cycle, apoptosis, and migration assays.
- Western blotting to assess protein levels and identify target genes, including activating transcription factor 2 (ATF2).
Main Results:
- miR-204 expression was significantly decreased in NSCLC tissues compared to non-neoplastic tissues.
- Overexpression of miR-204 suppressed NSCLC cell proliferation and migration while inducing apoptosis and G1 arrest.
- ATF2 was identified as a direct target of miR-204, with inverse correlation observed between their expression levels in NSCLC tissues and cell lines.
Conclusions:
- miR-204 functions as a tumor suppressor in NSCLC.
- The tumor-suppressive role of miR-204 is mediated, at least in part, by the direct targeting of ATF2.
- Restoring miR-204 levels may represent a potential therapeutic strategy for NSCLC.
Related Concept Videos
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
lncRNA - Long Non-coding RNAs

